RecallRadar

FDA Drug recall D-1244-2020

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (…

On 2020-04-22 the FDA classified a Class II recall of Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (… by B And B Pharmaceuticals, citing cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1244-2020
ClassificationClass II
Statusterminated
Initiated2020-04-14
Published2020-04-22
Last updated2026-09-13 11:52 UTC
CompanyB And B Pharmaceuticals
DistributionUS

Product

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100

Reason

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Identifiers

code_infoLot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1244-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.